![](https://www.diabetesnews.com/wp-content/uploads/2014/03/diabetes_mellitus_-_insulin_treatment-2-150x150.jpg)
An ultra-rapid inhaled insulin that approximates glucose excursions following meals is a non-invasive, effective therapy for patients with type 1 or type 2 diabetes, according to research presented at the American Diabetes Association’s 74th Scientific Sessions.